Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita

22 Dec 2010

Abstract excerpt

Nishio N, Takahashi Y, Ohashi H, Doisaki S, Muramatsu H, Hama A, Shimada A, Yagasaki H, Kojima S. Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita. Pediatr Transplantation 2011: 15:161–166. © 2010 John Wiley & Sons A/S. Abstract: DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to Hematopoietic Stem Cell Transplantation
Share to Telomeres, Telomerase, and Senescence

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21176016
DOI: 10.1111/j.1399-3046.2010.01431.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced‐intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenitaPMID 21176016Read ↗

Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1.Semantic proximity Read ↗

Generation of Dyskeratosis Congenita-like Hematopoietic Stem Cells through the Stable Inhibition of DKC1Semantic proximity Read ↗

Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita.Semantic proximity Read ↗

The diagnosis and treatment of dyskeratosis congenita: a reviewSemantic proximity Read ↗

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Dyskeratosis CongenitaSemantic proximity Read ↗

Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantationSemantic proximity Read ↗

Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa.Semantic proximity Read ↗

Dyskeratosis congenita: The first NIH clinical research workshopSemantic proximity Read ↗

Exogenous <i>TERC</i> alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patientsSemantic proximity Read ↗

Clinical and genetic features of dyskeratosis congenita, cryptic dyskeratosis congenita, and Hoyeraal-Hreidarsson syndrome in Japan.Semantic proximity Read ↗

Irreversible leukoencephalopathy after reduced-intensity stem cell transplantation in a dyskeratosis congenita patient with TINF2 mutation.Semantic proximity Read ↗

Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.